Revvity, Inc. (RVTY) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Diagnostics & Research 산업에서 운영. 본사 소재지는 Waltham, MA, 미국. 현재 CEO는 Prahlad R. Singh.
RVTY 을(를) 보유 IPO 날짜 1965-07-06, 11,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $10.45B.
Revvity, Inc. is a global provider of products, services, and solutions serving the diagnostics, life sciences, and applied services markets. Operating through two primary segments, Discovery & Analytical Solutions and Diagnostics, the company offers a comprehensive portfolio including analytical instruments, reagents, software, and imaging technologies for research and industrial applications across pharmaceuticals, environmental monitoring, food production, and chemical analysis. The Diagnostics segment specializes in instruments and assay platforms for genetic disorder detection, infectious disease testing, and genomic workflows, serving pharmaceutical companies, biotechnology firms, laboratories, academic institutions, and healthcare organizations worldwide. Founded in 1937 and headquartered in Waltham, Massachusetts, Revvity rebranded from PerkinElmer, Inc. in April 2023 to reflect its evolved market positioning and capabilities.
